ArticleBMC biology2025
Accurate prediction of synergistic drug combination using a multi-source information fusion framework.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global trends in carbapenem-resistant gram-negative bacteria research (2020-2025): a bibliometric analysis and systematic review.Frontiers in cellular and infection microbiology · 2025Pooled it
- Momentum contrast-enhanced multimodal representation learning for drug synergy prediction.Bioinformatics (Oxford, England) · 2026Article
- Harnessing transcriptomics for discovery of natural products to overcome acquired cancer resistance.Archives of pharmacal research · 2026Review
- 3d electron cloud descriptors for enhanced QSAR modeling of anti-colorectal cancer compounds.Journal of computer-aided molecular design · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAccurately predicting synergistic drug combinations is critical for complex disease therapy. However, the vast search space of potential drug combinations poses significant challenges for identification through biological experiments alone. Nowadays, deep learning is widely applied in this field. However, most methods overlook the important role of protein-protein interaction networks formed by gene expression products and the pharmacophore information of drugs in predicting drug synergy.
resultsWe propose MultiSyn, a multi-source information integration method for the accurate prediction of synergistic drug combinations. Specifically, we design a semi-supervised learning framework using an attributed graph neural network to integrate protein-protein interaction networks of gene expression products with multi-omics data, constructing initial cell line representations that incorporate multi-source information. Furthermore, we refine the initial cell line representation by adaptively integrating it with normalized gene expression profiles, enabling the extraction of cell line features that encapsulate global information. In addition, we decompose drugs into fragments containing pharmacophore information based on chemical reaction rules and construct a heterogeneous graph comprising atomic and fragment nodes. To enhance the capture of molecular structural information, we introduce a heterogeneous graph transformer to learn multi-view representations of heterogeneous molecular graphs. Extensive experiments show that MultiSyn outperforms several classical and state-of-the-art baselines in synergistic drug combination prediction tasks.
conclusionsThis study provides a powerful tool for inferring promising synergistic drug combinations. By leveraging attention mechanisms and pharmacophore information, MultiSyn identifies key substructures that are critical for synergy. Further visualization and case studies validate its effectiveness in capturing biologically meaningful features and identifying potential drug combinations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.